| Symbol | AIM |
|---|---|
| Name | AIM IMMUNOTECH INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 2117 SW HIGHWAY 484, OCALA, FL 32801 |
| Telephone | 352-448-7797 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000946644 |
| Description | None |
AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program
Read moreNew Form DEF 14A - AIM ImmunoTech Inc. <b>Filed:</b> 2026-06-25 <b>AccNo:</b> 0001493152-26-030043 <b>Size:</b> 1 MB
Read moreAIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
Read moreNew Form EFFECT - AIM ImmunoTech Inc. <b>Filed:</b> 2026-06-23 <b>AccNo:</b> 9999999995-26-002094 <b>Size:</b> 1 KB
Read moreAIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
Read moreNew Form S-1 - AIM ImmunoTech Inc. <b>Filed:</b> 2026-06-18 <b>AccNo:</b> 0001493152-26-029193 <b>Size:</b> 913 KB
Read moreNew Form EFFECT - AIM ImmunoTech Inc. <b>Filed:</b> 2026-06-16 <b>AccNo:</b> 9999999995-26-002022 <b>Size:</b> 1 KB
Read moreNew Form PRE 14A - AIM ImmunoTech Inc. <b>Filed:</b> 2026-06-15 <b>AccNo:</b> 0001493152-26-028732 <b>Size:</b> 1 MB
Read more(80% Positive) AIM IMMUNOTECH INC. (AIM) Announces Enrollment Update for investors Due to Patient Enrollment Issues, Regulatory Process, Efficacy Assessment
Read more